GSRCX
Price
$11.63
Change
+$0.10 (+0.87%)
Updated
Jun 6 closing price
Net Assets
431.85M
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

GSRCX vs VIVAX

Header iconGSRCX vs VIVAX Comparison
Open Charts GSRCX vs VIVAXBanner chart's image
Goldman Sachs Rising Dividend Gr C
Price$11.63
Change+$0.10 (+0.87%)
VolumeN/A
Net Assets431.85M
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
GSRCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSRCX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. GSRCX (432M). VIVAX pays higher dividends than GSRCX: VIVAX (2.16) vs GSRCX (0.67). GSRCX was incepted earlier than VIVAX: GSRCX (20 years) vs VIVAX (33 years). GSRCX (2.02) is less costly to investors than VIVAX (0.17). GSRCX is a more actively managed with annual turnover of: 42.00 vs. VIVAX (9.00). GSRCX has a lower initial minimum investment than VIVAX: GSRCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. GSRCX (-6.66). VIVAX return over 5 years is better than : 58.70 vs. GSRCX (19.12).
GSRCXVIVAXGSRCX / VIVAX
Total Expense Ratio1.760.171,035%
Annual Report Gross Expense Ratio2.020.171,188%
Fund Existence20 years33 years-
Gain YTD0.2341.23819%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets432M189B0%
Annual Yield % from dividends0.672.1631%
Returns for 1 year-6.666.81-98%
Returns for 3 years-3.9318.51-21%
Returns for 5 years19.1258.7033%
Returns for 10 years-40.75102.90-40%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc